← Back
Data updated: Mar 10, 2026
PHARMASCIENCE INC
Oncology
PHARMASCIENCE INC is a generic drug manufacturer focused on Oncology. Key products include DECITABINE.
2017
Since
5
Drugs
-
Trials
19
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
BORTEZOMIB 2026-01-06
DECITABINE 2025-12-19
BORTEZOMIB 2025-12-17
DECITABINE 2025-07-01
Labeling
DECITABINE 2025-06-20
Labeling
DECITABINE 2025-06-20
Labeling
DECITABINE 2025-06-20
Labeling
BORTEZOMIB 2025-06-02
GANCICLOVIR SODIUM 2025-05-18
Labeling
DECITABINE 2025-04-02
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (1)
Company Info
- First Approval
- 2017-03-24
- Latest
- 2024-02-15
- Applications
- 7